Renzo Cecere, MD
Heart failure
heart assist devices
mitral valve
stem cells
medical device design
CHAL | Cardiovascular Health across the Lifespan Program
Our Researchers
The Cardiovascular Health Across the Lifespan (CHAL) Program brings together seven basic researchers, thirty clinician-scientists and eight health outcomes researchers. Researchers from the Centre for Translational Biology (CTB) conduct basic research projects related to vascular function and related diseases, especially atherosclerosis, hypercholesterolemia and vascular injury. Investigators from the Centre for Innovative Medicine (CIM) focus their research on surgery outcomes and on improving prevention and care in patients affected by such cardiac diseases as heart failure, arrhythmias and valve diseases. Investigators from the Centre for Outcomes Research and Evaluation (CORE) seek to develop networks, databases and new tools to improve population health. These include epidemiological outcome and intervention studies on congenital heart disease (CHD), and different factors (genetic, environmental, gender-based) for cardiovascular diseases. CHAL researchers are based at the Glen site, at the heritage site of the Royal Victoria Hospital of the MUHC and at 5252 de Maisonneuve Boulevard W.
Filters
Displaying 8 result(s).
|
CTB |
|
|
Stella Daskalopoulou, MD, M.Sc., DIC, PhDatherosclerosis vascular biology arterial stiffness and vessel hemodynamics hypertension cardiovascular risk factors CTB |
|
James Engert, PhDgenetic association studies single-nucleotide polymorphisms (SNPs) gene-environment interactions atherosclerosis aortic stenosis CTB |
|
Jacques Genest, MD, FRCP(C)lipoproteins high-density lipoprotein (HDL) familial hypercholesterolemia genetics ABCA1 CTB |
|
Robert Kiss, PhDcholesterol intracellular trafficking cell biology microscopy CTB |
|
Adel Schwertani, DM, PhDcardiology heart vasoactive substances atherosclerosis pulmonary hypertension CTB |
